<html><body><h2>Case: 1305827445718</h2>
<patient name=1004430>
56.0 year old White_Non-Hispanic Female
<p><b>Lab & Note Entry Values:</b> <table>
<b><tr><td width="200">Lab</td><td width="200">Value</td><td width="200">Date</td></tr></b>
<tr><td width="200">Age</td><td width="200">56</td><td width="200">1970-1-1</td></tr>
<tr><td width="200">UrineProtein_12h</td><td width="200">697</td><td width="200">1956-1-3</td></tr>
<tr><td width="200">Calcium</td><td width="200">9</td><td width="200">1956-1-3</td></tr>
<tr><td width="200">UrineProtein_24h</td><td width="200">697</td><td width="200">1956-1-3</td></tr>
<tr><td width="200">Alkaline_phosphatase</td><td width="200">139</td><td width="200">1955-12-6</td></tr>
<tr><td width="200">Phosphorus</td><td width="200">4</td><td width="200">1955-9-23</td></tr>
<tr><td width="200">LDL_Cholesterol</td><td width="200">67</td><td width="200">1955-8-7</td></tr>
<tr><td width="200">Chloride</td><td width="200">104.0</td><td width="200">1956-1-3</td></tr>
<tr><td width="200">HDL_Cholesterol</td><td width="200">24</td><td width="200">1955-8-7</td></tr>
<tr><td width="200">Diastolic_BP</td><td width="200">80</td><td width="200">1956-1-3</td></tr>
<tr><td width="200">BNP</td><td width="200">6,739</td><td width="200">1955-12-9</td></tr>
<tr><td width="200">B 12</td><td width="200">717.0</td><td width="200">1955-11-16</td></tr>
<tr><td width="200">Weight</td><td width="200">219</td><td width="200">1956-1-3</td></tr>
<tr><td width="200">Uric_Acid</td><td width="200">8</td><td width="200">1955-8-7</td></tr>
<tr><td width="200">HbA1C</td><td width="200">5</td><td width="200">1955-11-16</td></tr>
<tr><td width="200">Triglycerides</td><td width="200">56</td><td width="200">1955-8-7</td></tr>
<tr><td width="200">Total_Cholesterol</td><td width="200">102</td><td width="200">1955-8-7</td></tr>
<tr><td width="200">SGOT</td><td width="200">47</td><td width="200">1955-12-6</td></tr>
<tr><td width="200">Systolic_BP</td><td width="200">142</td><td width="200">1956-1-3</td></tr>
<tr><td width="200">Total_Bilirubin</td><td width="200">2</td><td width="200">1955-12-6</td></tr>
<tr><td width="200">Height</td><td width="200">69</td><td width="200">1956-1-3</td></tr>
<tr><td width="200">Potassium</td><td width="200">6</td><td width="200">1956-1-3</td></tr>
<tr><td width="200">Cholesterol</td><td width="200">102</td><td width="200">1955-8-7</td></tr>
<tr><td width="200">BUN</td><td width="200">75</td><td width="200">1956-1-3</td></tr>
<tr><td width="200">HCT</td><td width="200">23</td><td width="200">1955-12-9</td></tr>
<tr><td width="200">HGB</td><td width="200">8</td><td width="200">1955-12-9</td></tr>
<tr><td width="200">Sodium</td><td width="200">136</td><td width="200">1956-1-3</td></tr>
<tr><td width="200">Albumen</td><td width="200">4</td><td width="200">1955-12-6</td></tr>
<tr><td width="200">Creatinine</td><td width="200">3.3</td><td width="200">1956-1-3</td></tr>
<tr><td width="200">Glycosylated_Hemoglobin</td><td width="200">5</td><td width="200">1955-11-16</td></tr>
<tr><td width="200">UrineProtein_Qualitative</td><td width="200">697.0</td><td width="200">1956-1-3</td></tr>
<tr><td width="200">UrineProtein_Spot</td><td width="200">697</td><td width="200">1956-1-3</td></tr>
<tr><td width="200">Pulse</td><td width="200">98</td><td width="200">1956-1-3</td></tr>
<tr><td width="200">PLT</td><td width="200">129</td><td width="200">1955-12-9</td></tr>
<tr><td width="200">WBC</td><td width="200">3</td><td width="200">1955-12-9</td></tr>
<tr><td width="200">eGFR</td><td width="200">31</td><td width="200">1955-9-23</td></tr>
<tr><td width="200">SGPT</td><td width="200">21</td><td width="200">1955-12-6</td></tr>
<tr><td width="200">nausea</td><td width="200"></td><td width="200">1955-12-13</td></tr>
<tr><td width="200">Liver_Disease</td><td width="200"></td><td width="200">1955-12-23</td></tr>
<tr><td width="200">illicit drug use</td><td width="200"></td><td width="200">1955-9-24</td></tr>
<tr><td width="200">Hypertension</td><td width="200"></td><td width="200">1955-7-14</td></tr>
<tr><td width="200">Heart_Failure</td><td width="200"></td><td width="200">1955-12-23</td></tr>
<tr><td width="200">edema</td><td width="200"></td><td width="200">1956-1-3</td></tr>
<tr><td width="200">Coronary_Artery_Disease</td><td width="200"></td><td width="200">1955-7-26</td></tr>
<tr><td width="200">Depression</td><td width="200"></td><td width="200">1955-4-19</td></tr>
<tr><td width="200">Atrial_Fibrillation</td><td width="200"></td><td width="200">1955-11-26</td></tr>
<tr><td width="200">Cardiomegaly</td><td width="200"></td><td width="200">1955-11-26</td></tr>
<tr><td width="200">Race</td><td width="200">White_Non-Hispanic</td><td width="200"></td></tr>
<tr><td width="200">Sex</td><td width="200">Female</td><td width="200"></td></tr>
</table>
<p><b>Medications:</b> aspirin(81.0) spironolactone(50.0) atenolol(25.0) lisinopril(20.0) hydrochlorothiazide(50.0) furosemide(80.0) 
<p><b>Problems:</b> <table>
<tr><td width="200"><b>Problem Class</b></td><td width="200"><b>First/Last Dates Reported</b></td><td width="200"></td></tr>
<tr><td width="200">Isolated_Systolic_Hypertension</td>
<td width="200"></td>
<td width="200"> Isolated Systolic Hypertension[Treatment_Systolic_BP(142/null) && Treatment_Diastolic_BP(80/null)]()</td></tr>
<tr><td width="200">Laboratory_Test_Result_Syndrome</td>
<td width="200"></td>
<td width="200"> Hyperuricemia[Uric_Acid(8.5/1955-8-7)]()</td></tr>
<tr><td width="200">Renal_insufficiency_w_creat>=2.1</td>
<td width="200"></td>
<td width="200"> Renal Insufficiency[Creatinine(3.3/1956-1-3)]()</td></tr>
<tr><td width="200">Target_Organ_Damage_Clinical_Cardiovascular_Disease</td>
<td width="200"></td>
<td width="200"> TOD/CCD[presence of cononary artery disease]()</td></tr>
<tr><td width="200">Isolated_Systolic_Hypertension K >=3.5</td>
<td width="200"></td>
<td width="200"> Isolated Systolic Hypertension[presence of isolated systolic hypertension && Potassium(5.5/1956-1-3)]()</td></tr>
<tr><td width="200">Dyslipidemia Lab criteria</td>
<td width="200"></td>
<td width="200"> Dyslipidemia Lab criteria[HDL_Cholesterol(24.0/1955-8-7)]()</td></tr>
<tr><td width="200">Heart Failure and BP not controlled</td>
<td width="200"></td>
<td width="200"> Heart Failure[presence of heart failure && BP not adequately controlled based on most recent BPTreatment_Systolic_BP(142/null)]()</td></tr>
<tr><td width="200">HCTZ >25mg</td>
<td width="200"></td>
<td width="200"> HCTZ >25mg[hctz >25mg]()</td></tr>
<tr><td width="200">ISH on HCTZ and BP not controlled</td>
<td width="200"></td>
<td width="200"> Isolated Systolic Hypertension[presence of isolated systolic hypertension && presence of HCTZ && BP not adequately controlled based on most recent BPTreatment_Systolic_BP(142/null)]()</td></tr>
<tr><td width="200">Presence of K sparing diuretics</td>
<td width="200"></td>
<td width="200"> K sparing diuretics[presence of K sparing diuretics]()</td></tr>
<tr><td width="200">Major Cardiovascular Risk Factor</td>
<td width="200"></td>
<td width="200"> Major Cardiovascular Risk Factor[Sex(Female) && Age(56.0/1970-1-1)]()</td></tr>
<tr><td width="200">Dyslipidemia Lab or ICD9</td>
<td width="200"></td>
<td width="200"> Dyslipidemia Lab or ICD9[presence of dyslipidemia lab criteria]()</td></tr>
<tr><td width="200">CKD by eGFR</td>
<td width="200"></td>
<td width="200"> CKD by eGFR[eGFR(31.0/1955-9-23)]()</td></tr>
<tr><td width="200">CKD by eGFR or ICD9 codes</td>
<td width="200"></td>
<td width="200"> CKD[eGFR(31.0/1955-9-23)]()</td></tr>
<tr><td width="200">On meds & Presence of strong contraindication to HCTZ or using bad drug partner</td>
<td width="200"></td>
<td width="200"> Hypertension[taking furosemide && Antihypertensive_Agents]()</td></tr>
<tr><td width="200">Active prescription for thiazide</td>
<td width="200"></td>
<td width="200"> active prescription for thiazide[presence of thiazide diuretics]()</td></tr>
<tr><td width="200">active prescription for furosemide</td>
<td width="200"></td>
<td width="200"> active prescription for furosemide[taking furosemide]()</td></tr>
<tr><td width="200">on >= 1 med</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">taking >= 2 anti hypertensive meds</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">On 1 drug and there exists contraindicated drug or a compelling drug not given</td>
<td width="200"></td>
<td width="200"> On 1 drug and there exists contraindicated drug or a compelling drug not given[there exists a compellingly indicated drug that is not already given]()</td></tr>
<tr><td width="200">Active prescription for ACE and aldosterone antagonists</td>
<td width="200"></td>
<td width="200"> Active prescription for ACE and aldosterone antagonists[ACE I being used && presence of aldosterone antagonist]()</td></tr>
<tr><td width="200">Absence of Stage D HF</td>
<td width="200"></td>
<td width="200"> Absence of Stage D HF[Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF)]()</td></tr>
<tr><td width="200">Female and most recent creatinine  >2</td>
<td width="200"></td>
<td width="200"> Female and most recent creatinine  >2[Sex(Female) && Creatinine(3.3/1956-1-3)]()</td></tr>
<tr><td width="200">Most recent K>=5</td>
<td width="200"></td>
<td width="200"> Most recent K>=5[Potassium(5.5/1956-1-3)]()</td></tr>
<tr><td width="200">Hepatobiliary_Diseases</td>
<td width="200">1955-12-23</td>
<td width="200"> Liver_Disease()</td></tr>
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Active Liver Disease[SGOT(47.0/1955-12-6)]()</td></tr>
<tr><td width="200">CCS-7.2</td>
<td width="200">1955-12-23</td>
<td width="200"> Heart_Failure()</td></tr>
<tr> <td width="200"></td>
<td width="200">1955-11-26</td>
<td width="200"> Cardiomegaly()</td></tr>
<tr> <td width="200"></td>
<td width="200">1955-07-26</td>
<td width="200"> Coronary_Artery_Disease()</td></tr>
<tr> <td width="200"></td>
<td width="200">1955-11-26</td>
<td width="200"> Atrial_Fibrillation()</td></tr>
<tr><td width="200">Hypertension_Inclusive</td>
<td width="200">1955-07-14</td>
<td width="200"> Hypertension()</td></tr>
<tr><td width="200">Psychiatric_Diseases</td>
<td width="200">1955-04-19</td>
<td width="200"> Depression()</td></tr>
<tr><td width="200"> <b>Others</b></td>
<td width="200">1955-12-13</td>
<td width="200"> nausea()
<tr> <td width="200"></td>
<td width="200">1956-01-03</td>
<td width="200"> edema()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Race()
<tr> <td width="200"></td>
<td width="200">1955-09-24</td>
<td width="200"> illicit drug use()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Sex()
</table><p>
<p><b>Allergies and Adverse Reactions:</b> <ul>
<li>Substance: aspirin Reaction: 
<li>Substance: aspirin Reaction: 
 </ul>
</patient>
<h1 align="center">ATHENA Heart Failure Guideline</h1>
<b>Patient classification:</b> <ul>
<li>ATHENA Heart Failure Guideline: true[because <i> Eligibility criteria </i> evaluate to <b>true</b><i>(Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF))</i>]
</ul>
<b>Scenario choice:</b> Stage C HF
<p>
<b>Goal:</b> LDL< 160 mg/dL(0-1 risk factors)
<p><b>Reached goal?</b> achieved(LDL_Cholesterol(67.0/1955-8-7))
<p>
<b>Goal:</b> SBP < 140 and DBP < 90(absence of diabetes mellitus)
<p><b>Reached goal?</b> failed(Treatment_Systolic_BP(142/null))
<p><b>Messages by Types</b>
<ul>
<li><b>Class II a</b>
<ul>
<li>It is reasonable to treat patients with atrial fibrillation and HF with a strategy to maintain sinus rhythm or with a strategy to control ventricular rate alone. (Level of Evidence: A)
<li>Maximal exercise testing with or without measurement of respiratory gas exchange is reasonable to facilitate prescription of an appropriate exercise program for patients presenting with HF. (Level of Evidence: C)
</ul>
<li><b>Class I</b>
<ul>
<li>Exercise training is beneficial as an adjunctive approach to improve clinical status in ambulatory patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: B)
<li>Coronary revascularization should be recommended in appropriate patients without symptoms of HF in accordance with contemporary guidelines (see ACC/AHA/ACP-ASIM Guidelines for the Management of Patients With Chronic Stable Angina).
</ul>
<li><b>Class III</b>
<ul>
<li>Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.
</ul>
</ul>
<p><b>Action Choices</b>
<ul>
<li><b>Stage C HF</b><br>
<ul>
</ul>
<li><b> </b><br>
<ul>
<li><b>General Recommendations <font color=FF0000>preferred</font></b>(strict rule-in condition<i> HF ICD9 code OR( signs and structural abnormality)</i> evaluate to <b> true</b> because <i>Presence of HF</i>)])
Exercise training is beneficial as an adjunctive approach to improve clinical status in ambulatory patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: B)
It is reasonable to treat patients with atrial fibrillation and HF with a strategy to maintain sinus rhythm or with a strategy to control ventricular rate alone. (Level of Evidence: A)
Maximal exercise testing with or without measurement of respiratory gas exchange is reasonable to facilitate prescription of an appropriate exercise program for patients presenting with HF. (Level of Evidence: C)

<li><b>Referrals <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])
Class I
<li><b>Stage B HF action <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])

Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.
Coronary revascularization should be recommended in appropriate patients without symptoms of HF in accordance with contemporary guidelines (see ACC/AHA/ACP-ASIM Guidelines for the Management of Patients With Chronic Stable Angina).
</ul>
</ul>
<b>Considerations for adding drug: </b><ul>
<li>No comment
</ul>
<li>No comment
</ul>
<li>No comment
</ul>
</ul>
</ul>
<b>Considerations for adding drug: </b><ul>
<li>No comment
</ul>
<li>No comment
</ul>
</ul>
</ul>
</ul>
</ul>
</ul>
</body></html>